We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+15.98%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.16B
AUM Growth
-$141M
Cap. Flow
-$287M
Cap. Flow %
-24.69%
Top 10 Hldgs %
33.33%
Holding
202
New
61
Increased
6
Reduced
14
Closed
41

Sector Composition

Rank Sector Weight
1 Healthcare 18.61%
2 Consumer Discretionary 13.24%
3 Financials 12.67%
4 Communication Services 11.29%
5 Technology 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUBWU
176
Lionheart Holdings Unit
CUBWU
-100,000
Closed -$999K
MACIU
177
Melar Acquisition Corp I Unit
MACIU
$170M
-150,000
Closed -$1.5M
FLD
178
Fold Holdings
FLD
$22.9M
-219,451
Closed -$2.37M
OSRHW
179
OSR Health Warrant
OSRHW
$304K
-204,072
Closed -$2.2M
AIEV
180
DELISTED
Thunder Power Holdings, Inc. Common Stock
AIEV
-185,064
Closed -$305K
HCVI
181
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
-207,500
Closed -$2.19M
WINVR
182
DELISTED
WinVest Acquisition Corp. Right
WINVR
-1,479,110
Closed -$111K
PRLH
183
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
-249,158
Closed -$2.75M
CTLT
184
DELISTED
CATALENT, INC.
CTLT
-461,981
Closed -$26M
EVE
185
DELISTED
EVe Mobility Acquisition Corp
EVE
-94,760
Closed -$1.05M
SBXC
186
DELISTED
SilverBox Corp III
SBXC
-449,798
Closed -$4.77M
CDAQ
187
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
-26,837
Closed -$292K
BHAC
188
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
-53,908
Closed -$577K
ASCBR
189
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
-1,950,000
Closed -$137K
ASCBW
190
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
-643,525
Closed -$7.21M
AOGOW
191
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
-949,909
Closed -$10.4M
AOGO
192
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
-217,523
Closed -$2.39M
CLOER
193
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
-1,500,000
Closed -$333K
FEXDR
194
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
-1,499,400
Closed -$165K
TENKR
195
DELISTED
TenX Keane Acquisition Right
TENKR
-1,500,000
Closed -$484K
IMAQW
196
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
-900,000
Closed -$10.3M
CETUR
197
DELISTED
Cetus Capital Acquisition Corp. Right
CETUR
-107,984
Closed -$30.8K
MCACW
198
DELISTED
Monterey Capital Acquisition Corporation Warrants
MCACW
-1,280,455
Closed -$14.5M
CNGLW
199
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
-906,104
Closed -$9.45M
NPABW
200
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
-96,543
Closed -$1.21M

Similar funds

Mangrove Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Mangrove Partners held 202 positions worth $1.16B, down 11% from $1.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Mangrove Partners withdrew a net $287M in Q3 2024, closing 41 positions and reducing 14 holdings. Its most notable exit was Albertsons Companies, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Keros Therapeutics worth $16.7M.

  • Mangrove Partners's largest Q3 2024 buy was Keros Therapeutics: 286,995 shares worth $16.7M.
  • Mangrove Partners added most to Liberty Broadband Class C in Q3 2024, an estimated $13.4M increase.
  • Mangrove Partners's biggest Q3 2024 reduction was Jackson Financial, cutting an estimated $23.5M.
  • Mangrove Partners fully exited Albertsons Companies in Q3 2024, selling an estimated $42.2M.
  • Mangrove Partners's ten largest holdings make up 33% of its $1.16B portfolio in Q3 2024.
  • Mangrove Partners opened 61 new positions and closed 41 in Q3 2024.
  • Mangrove Partners's portfolio value fell 11% quarter-over-quarter to $1.16B.

Based on Mangrove Partners's 13F filing for Q3 2024, filed 14 Nov 2024.